Reversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity

MoclobemideSummaryTherapeutic doses of Moclobemide combined with any (S)SRI carries a significant risk of potentially fatal serotonin toxicity. This is especially so when multiple pharmaco-kinetic interactions via CYP-450 come into play.IntroductionMoclobemide…

Continue ReadingReversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity